EcoR1 Reports ZYME, JANX Activity

JC Parets
January 24, 2023

The largest insider buy on today's list is a Form 4 filing by EcoR1 Capital LLC, which reported a purchase of roughly $2.9 million in Zymeworks Inc $ZYME.

EcoR1 Capital also filed a Form 13G, disclosing a stake of 7.80% in the cancer biotech stock Janux Therapeutics $JANX.

There was another 13G filed by Invenire Partners, which revealed an initial stake of 5.50% in CompoSecure $CMPO.

Here’s The Hot List, with data through January 23, 2023:

In a Form 4, Swiss investment company BB Biotech revealed a purchase of 150,000 shares of NGM Biopharmaceuticals $NGM stock.

In the options market, there was bullish flow in Unity Software $U, Boot Barn Holdings $BOOT and Paramount Group $PARA.

The only stock that experienced bearish flow was Campbell Soup Company $CPB.

Stay tuned. We'll be back on Wednesday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under